Possible influence of foodstuff on the metabolism of some tyrosine kinase inhibitors;Möglicher Einfluss von Lebensmitteln auf die Metabolisierung einiger Tyrosinkinase- Inhibitoren

Deutsche Zeitschrift fur Onkologie

Volumn 45, Issue 3, 2013, Pages 112-115

  Kronabel, Dieter ^a  

^a NONE   (Germany)

Author keywords

Axitinib; Erlotinib; foodstuff; Gefitinib; Ibrutinib; Imatinib; Interactions; Pazopanib; substances of secondary metabolism; tyrosine kinase inhibitors

Indexed keywords

CYTOCHROME P450 1A2; CYTOCHROME P450 3A4; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; FUROCOUMARIN; POLYCYCLIC AROMATIC HYDROCARBON; PROTEIN TYROSINE KINASE INHIBITOR; SUNITINIB;

ARTICLE; CANCER INHIBITION; DRUG METABOLISM; DRUG PROTEIN BINDING; ENZYME INHIBITION; FOOD; GRAPEFRUIT; PROTEIN METABOLISM; SMOKING; TEA;

EID: 84886885439     PISSN: 16175891     EISSN: 14390930     Source Type: Journal    
DOI: 10.1055/s-0033-1334403     Document Type: Article

References (25)

1. Dong-Wook K., Tan E. Y., Jin Y. et al. Effects of imatinib mesylate on the pharmacokinetics of paracetamol (acetaminophen) in Korean patients with chronic myelogenous leukaemia. Br J Clin Pharmacol: 2011; 1(2) 199 206
2. Chen Y., Liu W. H., Chen B. L. et al. Plant polyphenol curcumin significantly affects CYP1A2 and CYP2A6 activity in healthy, male Chinese volunteers. Ann Pharmacother: 2010; 44(6) 1038 1045
3. Chen Y., Tortorici M. A., Garrett M. et al. Clinical Pharmacology of Axitinib. Clin Pharmacokinet: 2013; 2S. (online publiziert am 16. Mai 2013)
4. Fuchs K. Untersuchungen der Toxizität von Umweltchemikalien in gentechnisch veränderten Zellen [Dissertation]. München LMU München: 2006
5. Hombrecher A. Molecular Modelling. Studien am humanen Cytochrom P450 1A2 [Dissertation]. Düsseldorf Universität Düsseldorf: 2005
6. Hou X. L., Takahashi K., Kinoshita N. et al. Possible inhibitory mechanism of Curcuma drugs on CYP3A4 in 1alpha, 25 dihydroxyvitamin D3 treated Caco-2 cells. Int J Pharm: 2007; 337(1-2) 169 177 (Pubitemid 46756042)
7. Hughes A. N. O'Brien MER Petty W. J. et al. Overcoming CYP1A1/1A2 Mediated Induction of Metabolism by Escalating Erlotinib Dose in Current Smokers. JCO: 2009; 27 1220 1226
8. Iwasaki R., Ito K., Ishida T. et al. Catechin, green tea component, causes caspase-independent necrosis-like cell death in chronic myelogenous leukaemia. Cancer Sci: 2009; 100(2) 349 356
9. Jun G., Ben-Xu T., Ye C. et al. Interaction of green tea polyphenol epigallocatechin-3-gallate with sunitinib: potential risk of diminished sunitinib bioavailability. J Mol Med: 2011; 89 595 602
10. Kang A. Y., Young L. R., Dingfelder C., Peterson S. Effects of furanocoumarins from apiaceous vegetables on the catalytic activity of recombinant human cytochrome P-450 1A2. Protein J: 2011; 30(7) 447-456
11. Klaassen T. Entwicklung und Validierung von Phä notypisierungsmethoden für die Cytochrom P450 -Enzyme CYP1A2,CYP2B6, CYP2C9 und CYP2C19 des Menschen [Dissertation]. Bonn Universität Bonn: 2006
12. Kronabel D. Möglicher Einfluss von Lebensmitteln auf die Metabolisierung von Tamoxifen. Dtsch Z Onkol: 2013; 45 14 17
13. Lee J. Y., Lee Y. M., Chang G. C. et al. Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy. PLOS one: 2011; 6(8) e23756
14. Li J., Zhao M., He P. et al. Differential metabolism of gefitinib and erlotinib by human cytochrome P450 enzymes. Clin Cancer Res: 2007; 13(12) 3731 3737 (Pubitemid 46955138)
15. Nautiyal J., Kanwar S., Yu Y. Majumdar APN Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells. Journal of Molecular Signaling: 2011; 6 7
16. Peterson S., Lampe J. W., Bammler T. K. et al. Apiaceous vegetable constituents inhibit human cytochrome P-450 1A2 (hCYP1A2) activity and hCYP1A2-mediated mutagenicity of aflatoxin B1. Food Chem Toxicol: 2006; 44(9) 1474 1484 (Pubitemid 43994282)
17. Peterson S., Schwarz Y. et al. CYP1A2, GSTM1 and GSTT1 Polymorphisms and Diet Effects on CYP1A2 Activity in a Crossover Feeding Trial. Cancer Epidemiol Biomarkers Prev: 2009; 18 3118
18. Stang M. M. Wirkung von Anthocyanen und Procyanidinen auf die Cytochrom P450 Isoenzyme 1A2 und 2C19 [Dissertation]. Regensburg Universität Regensburg: 2012
19. Tortorici M. A., Toh M., Rahavendran S. V. et al. Influence of mild and moderate hepatic impairment on axitinib pharmacokinetics. Invest New Drugs: 2011; 6 1370 1380
20. van Erp N., Gelderblom H., v. Glabbeke M. et al. Effect of Cigarette Smoking on Imatinib in Patients in the Soft Tissue and Bone Sarcoma Group of the EORTC. Clin Cancer Res: 2008; 14(24) 8308 8313
21. van Erp N. P., Baker S. D., Zandvliet A. S. et al. Marginal increase of sunitinib exposure by grapefruit juice. Cancer Chemother Pharmacol: 2011; 3 695 703
22. Waller L. L., Miller A. A., Petty W. J. Using erlotinib to treat patients with non-small cell lung cancer who continue to smoke. Lung Cancer: 2010; 67(1) 12 16
23. Xu C. F., Reck B. H., Xue Z. et al. Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism. Br J Cancer: 2010; 102(9) 1371 1377
24. Yin O. Q., Gallagher N., Li A. et al. Effect of grapefruit juice on the pharmacokinetics of nilotinib in healthy participants. J Clin Pharmacol: 2010; 50(2) 188 194
25. Zhang X., Zhang H., Tighiouart M. et al Synergistic inhibition of head and neck tumor growth by green tea epigallocatechin-3-gallate and EGFR tyrosine kinase inhibitor. Int J Cancer: 2008; 123(5) 1005 1014